MicroRNAs and Tumor Angiogenesis.

doi:10.13701/j.cnki.kqyxyj.2017.08.025

Abstract

Abstract: Angiogenesis, the process of forming neovascular structure from preexisting blood vessels, is closely related with tumor growth, metastasis, relapse, drug resistance via the supply of nutrients and grow factors. In this complicated regulatory network of tumor angiogenesis, microRNAs play an important role and even act as an accurate biomarker or therapeutic target. In this paper, the effects of microRNAs on tumor angiogenesis were summarized.

Key words: MicroRNAs, Angiogenesis , Tumor

CLC Number:

R782

XIA Hou-fu, REN Jian-gang, ZHAO Yi-fang.. MicroRNAs and Tumor Angiogenesis.[J]. Journal of Oral Science Research, 2017, 33(8): 901-904.

References

[1] Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression [J]. Nat Rev Cancer, 2012, 12(9)∶613-626
[2] Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis [J]. Nature, 2011, 473(7347)∶298-307
[3] Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis [J]. Cell, 2011, 146(6)∶873-887
[4] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation [J]. Cell, 2011, 144(5)∶646-674
[5] Landskroner-Eiger S, Moneke I, Sessa WC. MiRNAs as modulators of angiogenesis [J]. Cold Spring Harb Perspect Med, 2013, 3(2)∶a006643
[6] Song ZF, Li GH. Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury [J]. J Cardiovasc Transl Res, 2010, 3(3)∶246-250
[7] Chou J, Payam S, Zena W. MicroRNA-mediated regulation of the tumor microenvironment [J]. Cell Cycle, 2013, 12(20)∶3262-3271
[8] Li LQ, Li H. Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors [J]. Cancer Biol Ther, 2013, 14(9)∶796-805
[9] Dang LT, Lawson ND, Fish JE. MicroRNA control of vascular endothelial growth factor signaling output during vascular development [J]. Arterioscler Thromb Vasc Biol, 2013, 33(2)∶193-200
[10] Kuninty PR, Schnittert J, Storm G, et al. MicroRNA targeting to modulate tumor microenvironment [J]. Front Oncol, 2016, 6∶3
[11] Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity [J]. Dev cell, 2008, 15(2)∶272-284
[12] Wang S, Aurora AB, Johnson BA, et al. An Endothelial-specific microRNA Governs Vascular Integrity and Angiogenesis [J]. Dev cell, 2008, 15(2)∶261-271
[13] Du C, Lv Z, Cao L, et al. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2 [J]. J Transl Med, 2014, 12∶259
[14] Zhu N, Zhang D, Xie H, et al. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2 [J]. Mol Cell Biochem, 2011, 351(1-2)∶157-164
[15] Sasahira T, Kurihara M, Bhawal UK, et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer [J]. Br J Cancer, 2012, 107(4)∶700-706
[16] Chen H, Li L, Wang S, et al. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A [J]. Oncotarget, 2014, 5(23)∶11873-11885
[17] Zhang Y, Wang X, Xu B, et al. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer [J]. Oncol Rep, 2013, 30(4)∶1976-1984
[18] Jusufovic E, Rijavec M, Keser D, et al. let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer [J]. PLoS One, 2012, 7(9)∶e45577
[19] Nichol D, Stuhlmann H. EGFL7: a unique angiogenic signaling factor in vascular development and disease [J]. Blood, 2012, 119(6)∶1345-1352
[20] Nicoli S, Knyphausen CP, Zhu LJ, et al. miR-221 is required for endothelial tip cell behaviors during vascular development [J]. Dev Cell, 2012, 22(2)∶418-429
[21] Koelz M, Lense J, Wrba F, et al. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors [J]. Int J Oncol, 2011, 38(2)∶503-511
[22] Elmasri H, Ghelfi E, Yu CW, et al. Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway [J]. Angiogenesis, 2012, 15(3)∶457-468
[23] Yang F, Wang W, Zhou C, et al. MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2 [J]. Tumour Biol, 2015, 36(5)∶3763-3773
[24] Santhekadur PK, Das SK, Gredler R, et al. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor kappaB and miR-221 [J]. J Biol Chem, 2012, 287(17)∶13952-13958
[25] Yang TQ, Lu XJ, Wu TF, et al. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-kappaB1/MMP9 signaling pathway [J]. Cancer Sci, 2014, 105(3)∶265-271
[26] Chamorro-Jorganes A, Araldi E, Penalva LO, et al. MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 [J]. Arterioscler Thromb Vasc Biol, 2011, 31(11)∶2595-2606
[27] Musumeci M, Coppola V, Addario A, et al. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer [J]. Oncogene, 2011, 30(41)∶4231-4242
[28] Dejean E, Renalier MH, Foisseau M, et al. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas [J]. Leukemia, 2011, 25(12)∶1882-1890
[29] Sun CY, She XM, Qin Y, et al. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF [J]. Carcinogenesis, 2013, 34(2)∶426-435
[30] Dai L, Wang W, Zhang S, et al. Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo [J]. Cell Biol Int, 2012, 36(8)∶765-770
[31] Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster [J]. Nat Genet, 2006, 38(9)∶1060-1065
[32] Jiang H, Wang P, Wang Q, et al.Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model [J]. Am J Pathol, 2014, 184(5)∶1355-1368
[33] Engelmann D, Mayoli-Nussle D, Mayrhofer C, et al. E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B [J]. J Mol Cell Biol, 2013, 5(6)∶391-403
[34] Skrzypek K, Tertil M, Golda S, et al. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis [J]. Antioxid Redox Signal, 2013, 19(7)∶644-660
[35] Chen LT, Xu SD, Xu H,et al.MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis [J]. Med Oncol, 2012, 29(3)∶1673-1680
[36] Chan JK, Kiet TK, Blansit K, et al. MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer [J]. Gynecol Oncol, 2014, 133(3)∶568-574
[37] Merritt WM, Lin YG, Spannuth WA, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth [J]. J Natl Cancer Inst, 2008, 100(5)∶359-372
[38] Pecot CV, Rupaimoole R, Yang D, et al. Tumour angiogenesis regulation by the miR-200 family [J]. Nat Commun, 2013, 4∶2427
[39] Kong D, Li Y, Wang Z, et al. The miR-200 regulates PDGF-D mediated epithelial-mesenchymal transition, adhesion and invasion of prostate cancer cells [J]. Stem Cells, 2009, 27(8)∶1712-1721
[40] Chan YC, Khanna S, Roy S, et al. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells [J]. J Biol Chem, 2011, 286(3)∶2047-2056
[41] Liu H, Brannon AR, Reddy AR, et al. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma [J]. BMC Syst Biol, 2010, 4∶51
[42] Roybal JD, Zang Y, Ahn YH, et al. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1 [J]. Mol Cancer Res, 2011, 9(1)∶25-35